XASXPWN
Market cap18mUSD
Jan 07, Last price
0.01AUD
1D
0.00%
1Q
-8.33%
Jan 2017
-50.00%
IPO
-93.94%
Name
Parkway Corporate Ltd
Chart & Performance
Profile
Parkway Corporate Limited, a cleantech company, provides water treatment solutions in Australia. It operates through three business units: Parkway Process Solutions, Parkway Process Technologies, and Parkway Ventures. The company offers analytical instruments for measuring water treatment related parameters; laboratory equipment; laboratory consumables, such as syringes, test tubes, measuring jugs, cylinders, and flasks; water treatment systems; and a range of pumps comprising specialty chemical dosing pumps, HVAC pumps, submersible pumps, and high-pressure and high-capacity pumps, as well as related parts and accessories. It also provides instrumentation and controllers to measure, monitor, and automate water treatment operations; pipe, hose, and fittings products; valves and solenoids; filters, membranes, and related process equipment; and a range of tanks for high-value industrial water treatment and process related applications. In addition, the company offers various water treatment chemicals; and disinfection products that consist of chemical disinfection, chlorination equipment, ozone disinfection, and UV disinfection products, as well as related parts and accessories. Further, it provides analytical testing, project evaluation, process development, project engineering, installation and project management, and operation and maintenance services. Additionally, the company holds interest in the Karinga Lakes potash project located in the northern territory of Australia; and owns a portfolio of industrial wastewater treatment technologies. The company was formerly known as Parkway Minerals NL and changed its name to Parkway Corporate Limited in September 2021. The company was incorporated in 2010 and is based in Sunshine North, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 8,898 109.50% | 4,247 25.82% | 3,376 931.36% | |||||||
Cost of revenue | 8,503 | 6,021 | 5,911 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 396 | (1,774) | (2,535) | |||||||
NOPBT Margin | 4.45% | |||||||||
Operating Taxes | (437) | 4 | ||||||||
Tax Rate | ||||||||||
NOPAT | 396 | (1,337) | (2,535) | |||||||
Net income | (734) -56.29% | (1,680) -27.96% | (2,332) 152.48% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 5,957 | 200 | 13 | |||||||
BB yield | -29.85% | 0.00% | -0.06% | |||||||
Debt | ||||||||||
Debt current | 422 | 336 | 173 | |||||||
Long-term debt | 14,170 | 4,922 | 2,090 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 555 | 177 | ||||||||
Net debt | 10,755 | 3,116 | (1,830) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 644 | (1,337) | (2,119) | |||||||
CAPEX | (174) | (398) | (1,307) | |||||||
Cash from investing activities | (3,778) | (435) | (1,343) | |||||||
Cash from financing activities | 4,622 | (227) | 13 | |||||||
FCF | (5,552) | (3,795) | (3,314) | |||||||
Balance | ||||||||||
Cash | 3,492 | 2,004 | 4,003 | |||||||
Long term investments | 345 | 138 | 90 | |||||||
Excess cash | 3,392 | 1,929 | 3,924 | |||||||
Stockholders' equity | 15,494 | 8,168 | 9,693 | |||||||
Invested Capital | 20,452 | 9,212 | 6,986 | |||||||
ROIC | 2.67% | |||||||||
ROCE | 1.66% | |||||||||
EV | ||||||||||
Common stock shares outstanding | 2,494,753 | 2,216,468 | 2,205,758 | |||||||
Price | 0.01 -20.00% | 0.01 0.00% | 0.01 -16.67% | |||||||
Market cap | 19,958 -9.96% | 22,165 0.49% | 22,058 -16.90% | |||||||
EV | 30,713 | 25,281 | 20,227 | |||||||
EBITDA | 983 | (1,343) | (2,268) | |||||||
EV/EBITDA | 31.24 | |||||||||
Interest | 254 | 53 | 22 | |||||||
Interest/NOPBT | 64.26% |